Protective effects of propolis and related polyphenolic/flavonoid compounds against toxicity induced by irinotecan

Medical Oncology

Volumn 27, Issue 4, 2010, Pages 1346-1358

  Oršolić, Nada ^a   Benković, Vesna ^a   Lisičić, Duje ^a   Dikić, Domagoj ^a   Erhardt, Julija ^a   Knežević, Anica Horvat ^a  

^a UNIVERSITY OF ZAGREB   (Croatia)

Author keywords

Chemoprevention; Ehrlich ascites tumors; Immunomodulatory effect; Irinotecan; Naringin; Propolis preparations; Quercetin

Indexed keywords

AURANTIIN; IRINOTECAN; POLYPHENOL DERIVATIVE; PROPOLIS; QUERCETIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER INHIBITION; CHEMOPROPHYLAXIS; CONTROLLED STUDY; DRUG CYTOTOXICITY; EHRLICH ASCITES TUMOR CELL; GENOTOXICITY; IMMUNOMODULATION; MALE; MICRONUCLEUS; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; BLOOD CELLS; CAMPTOTHECIN; CARCINOMA, EHRLICH TUMOR; CELLS, CULTURED; FLAVONOIDS; IMMUNOLOGIC FACTORS; INJECTIONS, INTRAPERITONEAL; KIDNEY; LIVER; MACROPHAGES, PERITONEAL; MALE; MICE; MICRONUCLEUS TESTS; PHENOLS; PROPOLIS;

EID: 79951768704     PISSN: 13570560     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12032-009-9387-5     Document Type: Article

References (54)

1. Lahouel M, Viotte G, Sumereau E, Morin JP, Fillastre JP. Haematotoxicity of doxorubicin and 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea (CCNU) and of their association in rats. Drugs Exp Clin Res. 1987;13(10):593-9. (Pubitemid 17155785)
2. Fillastre JP, Viotte G, Morin JP, Moulin B. Nephrotoxicity of antitumoral agents. Adv Nephrol Necker Hosp. 1988;17:175-218. Review.
3. Oršolić N, Štajcar D, Bašić I. Cytotoxicity of propolis and its polyphenolic compounds on primary culture of human urinary bladder transitional cell carcinoma. Pharmacologyonline. 2006;3:408-15.
4. Oršolić N, Bašić I. Cancer chemoprevention by propolis and its polyphenolic compounds in experimental animals (Phytochemistry and pharmacology III, Singh VK, Govil JN, C. Arunachalam, editors. USA: Studium Press). Recent Prog Med Plants. 2007;17:55-113.
5. Benkovic V, Horvat Knezevic A, Brozovic G, Knezevic F, Dikic D, et al. Enhanced antitumor activity of irinotecan combined with propolis and its polyphenolic compounds on Ehrlich ascites tumor in mice. Biomed Pharmacother. 2007;61(5):292-7. (Pubitemid 46900992)
6. Grynberg NF, Carvalho MG, Velandia JR, Oliveira MC, Moreira IC. DNA topoisomerase inhibitors: biflavonoids from Ouratea species. Braz J Med Biol Res. 2002;35:819-22. (Pubitemid 34919153)
7. Yamashita Y, Kawada S, Fujii N, Nakano H. Induction of mammalian DNA topoisomerase II dependent DNA cleavage by antitumor antibiotic streptonigrin. Cancer Res. 1990;50:5841-4. (Pubitemid 20331387)
8. López-Lázaro M, Martín-Cordero C, Toro MV, Ayuso MJ. Flavonoids as DNA topoisomerase I poisons. J Enzyme Inhibit Med Chem. 2006;233(2):255-64.
9. Webb MR, Ebeler SE. Comparative analysis of Topoisomerase IB inhibition and DNA intercalation by flavonoids and similar compounds: structural determinates of activity. Biochem J. 2004;384:527-41. (Pubitemid 40018966)
10. Constantinou A, Mehta R, Runyan C, Rao K, Vaughan A, Moon R. Flavonoids as DNA topoisomerase antagonists and poisons: structure-activity relationships. J Nat Prod. 1995;58(2):217-25.
11. Plowman J, Dykes DJ, Hollingshead M, Simpson-Herren L, Alley MC. Human tumor xenograft models in NCI drug development. In: Teicher B, editor. Anticancer development guide: preclinical screening, clinical trials, and approval. Totowa: Humana; 1997. p. 101-25.
12. Schluep T, Hwang J, Cheng J, Heidel JD, Barlett DW, et al. Preclinical efficacy of the camptothecin-polymer conjugate IT-101 in multiple cancer models. Clin Cancer Res. 2006;12(5):1606-14.
13. Oršolić N, Bašić I. Antitumor, hematostimulative and radioprotective action of water-soluble derivative of propolis (WSDP). Biomed Pharmacother. 2005;59(10):561-70. (Pubitemid 41820386)
14. Prasad KN, Cole WC, Kumar B, Prasad KC. Alpha tocopheryl succinate, retinoic acid and polar carotenoids enhanced the growth-inhibitory effect of a cholesterol-lowering drug on immortalized and transformed nerve cells in culture. J Am Coll Nutr. 2001;20(6):628-36. Review. (Pubitemid 34008061)
15. Lee R, Kim YJ, Lee YJ, Chung HW. The selective effect of genistein on the toxicity of bleomycin in normal lymphocytes and HL-60 cells. Toxicology. 2004;195(23):87-95. (Pubitemid 38125112)
16. Borek C. Dietary antioxidants and human cancer. Integr Cancer Ther. 2004;3(4):333-41. Review. (Pubitemid 39552427)
17. Orsolic N, Kosalec I, Basic I. Synergystic antitumor effect of polyphenolic components of water soluble derivative of propolis against Ehrlich ascites tumour. Biol Pharml Bull. 2005;28(4):694-700. (Pubitemid 40879940)
18. Popova M, Bankova V, Butovska D, Petkov V, Nikolova-Damyanova B, et al. Validated methods for the quantification of biologically active constituents of poplar-type propolis. Phytochem Anal. 2004;15:235-40.
19. Yang Chang CC, MH Yang, Wen HM, Chern JC. Estimation of total flavonoid content in propolis by two complementary colorimetric methods. J Food Drug Anal. 2002;10:178-82.
20. Ch Chen, Weng M, Ch Wu, Lin J. Comparison of radical scavenging activity, cytotoxic effects and apoptosis induction in human melanoma cells by Taiwanese propolis from different sources. Evid Based Complement Alternat Med. 2004;1(2):175-85.
21. Kosalec I, Bakmaz M, Pepeljnjak S. Analysis of propolis from the continental and Adriatic regions of Croatia. Acta Pharm. 2003;53(4):275-85. (Pubitemid 38083942)
22. Kosalec I, Bakmaz M, Pepelnjak S, Knežević S. Quantitative analysis of the flavonoids in raw propolis from northern Croatia. Acta Pharm. 2004;54:65-72. (Pubitemid 38524316)
23. Bergman RA, Afifi AK, Heidger PM. Histology. Philadelphia: Saunders; 1995.
24. Fecchio D, Sirois P, Russo M, Jancar S. Studies on inflammatory response induced by Ehrlich tumor in mice peritoneal cavity. Inflammation. 1990;14:125-32. (Pubitemid 20061425)
25. Rabinovitch M, Manejias RE, Russo M, Abbey EE. Increased spreading of macrophages from mice treated with interferon inducers. Cell Immunol. 1977;29:86-95. (Pubitemid 8070912)
26. Rabinovitch M, DeStefano MJ. Macrophage spreading in vitro. I. Inducers of spreading. Exp Cell Res. 1973;77:323-34.
27. Suzuki I, Hayashi I, Takaki T, Groveman DS, Fujimiya Y. Antitumor and anticytopenic effects of aqueous extracts of propolis in combination with chemotherapeutic agents. Cancer Biother Radiopharm. 2002;17(5):553-62. (Pubitemid 35231615)
28. Holden HE, Majeska JB, Studwell D. A direct comparison of mouse and rat bone marrow and blood as target tissues in the micronucleus assay. Mutat Res. 1997;391(1-2): 87-9. (Pubitemid 27263455)
29. Hayashi M, Hashimoto S, Sakamoto Y, Hamada C, Sofuni T, Yoshimura I. Statistical analysis of data in mutagenicity assays: rodent micronucleus assay. Environ Health Perspect. 1994;102(1):49-52. (Pubitemid 24083101)
30. Orsolic N, Brbot Saranovic A, Basic I. Direct and indirect mechanism (s) of antitumor activity of propolis and its polyphenolic compounds. Planta Med. 2005;72:14-9.
31. Kohno H, Tanaka T, Kawabata K, Hirose Y, Sugie Y, et al. Silymarin, a naturally occurring polyphenolic antioxidant flavonoid, inhibits azoxymethane-induced colon carcinogenesis in male F344 rats. Int J Cancer. 2002;101:461-8.
32. Hertog MG, Feskens EJ, Hollman PC, Katan MB, et al. Dietary antioxidant flavonoids and risk of coronary heart disease. The Zutphen elderly study. Lancet. 1993;342:1007-11. (Pubitemid 23314801)
33. Potter SM, Baum JA, Teng H, Stillman RJ, Shay NF, et al. Soy protein and isoflavones: their effects on blood lipids and bone density in postmenopausal women. Am J Clin Nutr. 1998;68:1375S-9S. (Pubitemid 28550915)
34. Joel SP, Shah R, Slevin ML. Etoposide dosage and pharmacodynamics. Cancer Chemother Pharmacol. 1994;34: S69-75. (Pubitemid 24264048)
35. Kobayashi K, Ratain MJ. Pharmacodynamics and long-term toxicity of etoposide. Cancer Chemother Pharmacol. 1994;34: S64-8. (Pubitemid 24264047)
36. Watson RW. Redox regulation of neutrophil apoptosis. Antioxid Redox Signal. 2002;4:97-104. (Pubitemid 34260690)
37. Hande KR. Etoposide pharmacology. Semin Oncol. 1992;19(6 Suppl 13): 3):3-9. Review. (Pubitemid 23056591)
38. Lamson DW, Brignall MS. Antioxidants and cancer therapy II: quick reference guide. Altern Med Rev. 2000;5:152-63. (Pubitemid 30226471)
39. Conklin KA. Cancer chemotherapy and antioxidants. J Nutr. 2004;134:3201S-4S. (Pubitemid 39470116)
40. Hogland HC. Hematologic complications of cancer chemotherapy. Semin Oncol. 1982;9(1):95-102.
41. Lahouel M, Boulkour S, Segueni N, Fillastre JP. Protective effect of flavonoids against the toxicity of vinblastine, cyclophosphamide and paracetamol by inhibition of lipid-peroxidation and increase of liver glutathion. Haema. 2004;7:59-67. (Pubitemid 38248390)
42. Fitzpatrick LR, Wang J, Le T. Caffeic acid phenethyl ester, an inhibitor of nuclear factor-kappaB, attenuates bacterial peptidoglycan polysaccharide-induced colitis in rats. J Pharmacol Exp Ther. 2001;299(3):915-20. (Pubitemid 33104959)
43. Ballester I, Camuesco D, Galvez J, Sanchez de Medina F, Zarzuelo A. Inhibition of pro-inflammatory markers in primary bone marrow-derived mouse macrophages by naturally occurring flavonoids: analysis of the structure-activity relationship. Biochem Pharmacol. 2006;72(8):1010-21. (Pubitemid 44374465)
44. Oršolić N, Horvat-Knežević A, Benković V, Bašić I. Benefits of use of propolis and related flavonoids against the toxicity of chemotherapeutic agents. Scientific evidence of the use of propolis in ethnomedicine. In: Oršolić N, Bašić I, editors. Ethnopharmacology-review book. India: Research Signpost; 2008. p. 195-222.
45. da Silva J, Herrmann SM, Heuser V, Peres W, Possa Marroni N, et al. Evaluation of the genotoxic effect of rutin and quercetin by comet assay and micronucleus test. Food Chem Toxicol. 2002;40(7):941-7. (Pubitemid 34626702)
46. Yen GC, Duh PD, Tsai HL, Huang SL. Pro-oxidative properties of flavonoids in human lymphocytes. Biosci Biotechnol Biochem. 2003;67(6):1215-22.
47. Rajkapoor B, Murugesh N, Chodon D, Sakthisekaran D. Chemoprevention of N-nitrosodiethylamine induced phenobarbitol promoted liver tumors in rat by extract of Indigofera aspalathoides. Biol Pharm Bull. 2005;28(2):364-6. (Pubitemid 40880026)
48. Boutet I, Meistertzheim A, Tanguy A, Thébault MT, Moraga D. Molecular characterization and expression of the gene encoding aspartate aminotransferase from the Pacific oyster Crassostrea gigas exposed to environmental stressors. Comp Biochem Physiol C Toxicol Pharmacol. 2005;140(1):69-78. (Pubitemid 40409881)
49. Mc Intyre N, Rosalki S. Biochemical investigations in the management of liver disease. In: Prieto J, Rodes J, Shafriz DA, editors. Hepatobiliary diseases.: Springer; 1992. p. 39-71.
50. Sforcin JM. Propolis and the immune system: a review. J Ethnopharmacol. 2007;113(1):1-14. Review. (Pubitemid 47077856)
51. Chopra S, Pillai KK, Husain SZ, Giri DK. Propolis protects against doxorubicin-induced myocardiopathy in rats. Exp Mol Pathol. 1995;62(3):190-8. (Pubitemid 26141517)
52. Sanz MJ, Ferrandiz MI, Cejudo M, Terencio MC, Gil B, et al. Influence of a series of natural flavonoids on free radical generating systems and oxidative stress. Xenobiotica. 1994;24(7):689-99. (Pubitemid 24269659)
53. Padmavathi R, Senthilnathan P, Sakthisekaran D. Therapeutic effect of propolis and paclitaxel on hepatic phase I and II enzymes and marker enzymes in dimethylbenz (a) anthraceneinduced breast cancer in female rats. Comp Biochem Physiol C Toxicol Pharmacol. 2006;143(3):349-54. (Pubitemid 43850414)
54. Kolankaya D, Selmanoglu G, Sorkun K, Salih B. Protective effects of Turkish propolis on alcohol-induced serum lipid changes and liver injury in male rats. Food Chem. 2002;78:13-217.